Richard Anthony Crowther

Title: Richard Anthony Crowther: Innovator in Alzheimer's Disease Research

Introduction

Richard Anthony Crowther is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of Alzheimer's disease research. His innovative approach focuses on the screening of agents that may be used in the treatment of this debilitating condition.

Latest Patents

Crowther holds a patent for a method of screening an agent for potential use in the treatment of Alzheimer's disease. This method involves reacting tau protein with a suitable sulphated carbohydrate under specific conditions to form filaments. The presence of these filaments is monitored to determine the effect of the agent being screened. If the formation of filaments is affected, it may indicate that the agent has an interfering, inhibiting, or blocking effect. This invention provides a valuable screening tool to identify agents that could be further investigated for therapeutic use in delaying the effects of Alzheimer's disease.

Career Highlights

Crowther is affiliated with the Medical Research Council, where he conducts his research. His work has been instrumental in advancing the understanding of Alzheimer's disease and exploring potential treatment options. He has dedicated his career to finding innovative solutions to complex medical challenges.

Collaborations

Some of Crowther's notable coworkers include Michel Goedert and Ross Jakes. Their collaborative efforts have contributed to the advancement of research in the field of neurodegenerative diseases.

Conclusion

Richard Anthony Crowther's innovative work in screening agents for Alzheimer's disease highlights his commitment to improving therapeutic options for patients. His contributions to the field are invaluable and continue to inspire further research and development.